Valerie A. Ivancic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Valerie A. Ivancic has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bethany Lee
Gustaf H. Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA 01610, USA
1 shared publication - Charles E. Jakobsche
Clark University, Department of Chemistry & Biochemistry, 950 Main Street, Worcester, Massachusetts 01610, United States
1 shared publication - Claire A. Krasinski
Gustaf H. Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA 01610, USA
1 shared publication - Donald E. Spratt
Gustaf H. Carlson School of Chemistry and Biochemistry Clark University Worcester Massachusetts USA
1 shared publication - Liliana A. Wurfl
Gustaf H. Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA 01610, USA
1 shared publication - Merc M. Kemeh
Gustaf H. Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA 01610, USA
1 shared publication
Latest Publications
- Open Access
- 25 August 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (9) , 1342
Differential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme
The insulin-degrading enzyme (IDE) possesses a strong ability to degrade insulin and Aβ42 that has been linked to the neurodegeneration in Alzheimer’s disease (AD). Given this, an attractive IDE-centric strategy for the development of therapeutics for AD is to boost IDE’s activity for the clearance of Aβ42 without offsetting insulin proteostasis. Recently, we showed that resveratrol enhances IDE’s activity toward Aβ42. In this work, we used a combination of chromatographic and spectroscopic techniques to investigate the effects of resveratrol on IDE’s activity toward insulin. For comparison, we also studied epigallocatechin-3-gallate (EGCG). Our results show that the two polyphenols affect the IDE-dependent degradation of insulin in different ways: EGCG inhibits IDE while resveratrol has no effect. These findings suggest that polyphenols provide a path for developing therapeutic strategies that can selectively target IDE substrate specificity.
- 25 August 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (9) , 1342
Open AccessDifferential Effects of Polyphenols on Insulin Proteolysis by the Insulin-Degrading Enzyme
The insulin-degrading enzyme (IDE) possesses a strong ability to degrade insulin and Aβ42 that has been linked to the neurodegeneration in Alzheimer’s disease (AD). Given this, an attractive IDE-centric strategy for the development of therapeutics for AD is to boost IDE’s activity for the clearance of Aβ42 without offsetting insulin proteostasis. Recently, we showed that resveratrol enhances IDE’s activity toward Aβ42. In this work, we used a combination of chromatographic and spectroscopic techniques to investigate the effects of resveratrol on IDE’s activity toward insulin. For comparison, we also studied epigallocatechin-3-gallate (EGCG). Our results show that the two polyphenols affect the IDE-dependent degradation of insulin in different ways: EGCG inhibits IDE while resveratrol has no effect. These findings suggest that polyphenols provide a path for developing therapeutic strategies that can selectively target IDE substrate specificity.